secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001104659-22-116216
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path Holdings raises $2.0M in registered direct offering with common warrants
--------------------------------------------------------------------------------

- Sold 800,000 shares at $2.50/share for gross proceeds ~$2.0M; net proceeds ~$1.7M after fees and expenses.
- Issued common warrants to buy 800,000 shares at $2.85; exercisable after 6 months, term 5.5 years.
- ROTH Capital Partners acted as placement agent; cash fee of 7.0% of gross proceeds plus expense reimbursement up to $50,000.
- Proceeds intended for working capital and general corporate purposes; closing expected November 9, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/0001104659-22-116216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/tm2230081d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-116216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer